tirzepatide drug test Wins FDA Approval for Weight Loss Mounjaro Tirzepatide Injections for Weight

Results from First Phase 2 Trial Describing a Triple Combination Regimen Targeting NASH Presented at The Liver Meeting Digital Experience

The realisation is that these gamechanger drugs are now making weight loss even easier, but as always our focus should be on the major challenge of weight maintenance

Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death

low intensity , the predominant energy source is those fatty acids , which will enter the cells, in the matrix of the organelle called mitochondria , which we could consider as our metabolic oven where the fatty acids will be oxidised after passing through various stages

Although clinical trial and real-world data on characterization and management of irAEs are beginning to emerge,1012 both types of data have critical limitations and gaps that hinder the ability to aggregate the data and conduct pooled analyses